Subjects at risk for AIDS, narcotic addicts and homosexuals develop a new syndrome of immunologic thrombocytopenic purpura (ITP) which has become part of the AIDS-related complex (ARC). This syndrome is associated with markedly elevated platelet bound IgG and C3C4, circulating immune complexes, and anti-F(ab')2 antibodies, suggesting an immune complex etiology. Narcotic addict patients, unlike homosexual patients, also have specific anti-platelet 7S IgG antibody. Unlike the situation with classic autoimmune thrombocytopenic purpura, there is no inverse correlation between platelet count and platelet-bound IgG. We propose to compare thrombocytopenic narcotic addicts (NITP) and homosexuals (HSITP) in order to: 1) Investigate the rate of conversion to AIDS over time, using a constant-risk model. Will all patients develop AIDS? Will there be a difference between NITP and HSITP patients? 2) Investigate the ability to culture virus from lymphocytes and semen in the presence and absence of plasma. This would determine a) whether ability to culture virus is related to resistance to disease; b) whether plasma neutralizing antibodies inhibit ability to culture virus and affect resistance to disease; c) relative infectivity of the narcotic addict group who are at risk for spread of virus to the heterosexual community. 3) Determine whether the lack of inverse correlation between platelet count and platelet-bound IgG in NITP and HSITP patients is due to reticulo-endothelial blockade. 4) Determine whether anti-F(ab')2 antibodies in NITP and HSITP patients are anti-idiotypic against anti-viral neutralizing antibodies. Can these regulate the patient's ability to handle HTLV-III infection? 5) Determine whether HTLV-III is present on platelets or within circulating immune complexes, to study the mechanism of the thrombocytopenia. 6) Determine antigenic determinants on platelets against which specific 7S autoantibody is directed in NITP patients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004315-02
Application #
3209793
Study Section
(SRCD)
Project Start
1986-09-30
Project End
1989-08-31
Budget Start
1987-09-30
Budget End
1988-08-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Wang, Jianhui; Zhang, Wei; Yi, Zanhua et al. (2012) Identification of a thrombin cleavage site and a short form of ADAMTS-18. Biochem Biophys Res Commun 419:692-7
Pan, Ruimin; Wang, Jianhui; Nardi, Michael A et al. (2011) The inhibition effect of anti-GPIIIa49-66 antibody on megakaryocyte differentiation. Thromb Haemost 106:484-90
Wang, Jianhui; Yi, Zanhua; Wang, Shiyang et al. (2011) The effect of decitabine on megakaryocyte maturation and platelet release. Thromb Haemost 106:337-43
Dang, Suying; Hong, Tao; Wisniewski, Thomas et al. (2011) Dissolution of pre-existing platelet thrombus by synergistic administration of low concentrations of bifunctional antibodies against ?3 integrin. PLoS One 6:e27012
Wang, J; Zhang, W; Nardi, M A et al. (2011) HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia. J Thromb Haemost 9:562-73
Zhang, Wei; Li, Yong-Sheng; Nardi, Michael A et al. (2010) Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus. Blood 116:2336-44
Zhang, Wei; Dang, Suying; Wang, Jianhui et al. (2010) Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66. Autoimmunity 43:682-9
Li, Zongdong; Nardi, Michael A; Li, Yong-Sheng et al. (2009) C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke. Blood 113:6051-60
Hu, Liang; Ibrahim, Sherif; Liu, Cynthia et al. (2009) Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222. Cancer Res 69:3374-81
Nardi, Michael A; Gor, Yelena; Feinmark, Steven J et al. (2007) Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase. Blood 110:1989-96

Showing the most recent 10 out of 25 publications